Assessing the Impact of Vidéo Remote Sign Language Interpreting in Healthcare

NCT05966623 | Unknown

• 1 other identifier: -2021-05-50-M1
• Study Type: interventional
• Target: 183
• Locations: 1 country
• Sites: 2

Brief Summary

This is a randomise study that looks at what is the effectiveness of the VRI system in improving communication outcomes between Deaf patients and doctors versus the 'available standard of care of the usual communication tools, including informal interpretation, lip or note reading, using their mobile phones to contact a formal or informal interpreter, for Deaf patients aged 18 and older in Bogota Colombia

Conditions

Deafness

Outcome Measures

Primary Outcomes (1)

• Communication outcomes

  The score of a selected' scale assesses A: creating a good interpersonal relationship, B: exchanging information, and C: Making treatment-related decisions that involve the patients in decision-making. The results of the scale will be asses using descriptive analytics (Fisher exact test will be applied to compare the 2 groups) Multiple regression analysis will be applied using demographic data and health indicators.

  12 months

Study Arms (2)

Experimental VRI sign language interpretation

EXPERIMENTAL

Participants will be provided with a Tablet of 14' inches with interrupted VRI in Colombian Sign Language. Professionally accredited Sign language interpreter. At the end of the hospital visit, they will complete a scale measuring Doctor-Patient-Communication

Other: Video Remote Interpretation

Experimental: primo control

NO INTERVENTION

Participants get welcome at the entry point of the hospital, they are not provided with VRI. At the end of the hospital visit, they will complete a scale measuring Doctor-Patient-communication

Interventions

Video Remote Interpretation OTHER

To assess the effectiveness of the VRI system in improving communication outcomes between Deaf patients and doctors Produce a VRI model addressing the challenges faced by Deaf people that will be tested, implemented, and sustained in Bogota Colombia.

Experimental VRI sign language interpretation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Uses Colombian Sign Language as the preferred language.
• Enough sensorimotor, cognitive and communication skills to communicate independently with health personnel

You may not qualify if:

• Does not communicate using sign language.
• Additional impairments which affect language development or the use of sign language.
• Refusal of the participant's representative(s) to participate in the study,
• Refusal of the participant's representative(s) to participate in a modality of the study,

Sponsors & Collaborators

• University of Geneva, Switzerland: lead
• Universidad del Rosario: collaborator
• Hospital Universitario Mayor Mederi: collaborator
• Clinica Nuestra Senora de la Paz: collaborator

Study Sites (2)

Clinica Nuestra Senora de la Paz

Bogotá, 110831, Colombia

Location

Hospital Universitario Mayor Mederi

Bogotá, 111411, Colombia

Location

Related Publications (2)

• Rivas Velarde M, Izquierdo Martinez LC, Dalal J, Martinez-R A, Guevara Rojas KL, Parra Valero NA, Cruz Reyes DL, Cuculick J, Vallejo-Silva A, Irreno-Sotomonte J, Groce N. Video Remote Sign Language Interpreting and Health Communication for Deaf Patients: A Randomized Clinical Trial. JAMA Netw Open. 2026 Feb 2;9(2):e2557189. doi: 10.1001/jamanetworkopen.2025.57189.

  PMID: 41637069 DERIVED

• Rivas Velarde M, Izquierdo Martinez LC, Dalal J, Martinez-R A, Cruz Reyes DL, Cuculick J, Vallejo-Silva A, Irreno-Sotomonte J, Groce N. Video Remote Sign Language Interpreting in Health Communication for Deaf People: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Dec 2;13:e64590. doi: 10.2196/64590.

  PMID: 39622021 DERIVED

MeSH Terms

Conditions

Deafness

Condition Hierarchy (Ancestors)

Hearing Loss; Hearing Disorders; Ear Diseases; Otorhinolaryngologic Diseases; Sensation Disorders; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: Single-blinded - The researcher needs to learn before the patient comes to the hospital as VRI needs to be organised. Thus, they will only know if the participants shall be assigned to the intervention or control group after the patient agrees to take part. Double blinding is not feasible as interpreters will not be available 24x7.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Group Leader

Model Details: Arm Intervention Experimental VRI sign language interpretation Participants will be welcome from their entry point to the hospital, they will attend a general check-up with a GP or other services and be provided with VRI until they leave Participants will be provided with a Tablet of 14' inches with interrupted VRI in Colombian Sign Language. Professionally accredited Sign language interpreter. At the end of the hospital visit, they will complete a scale measuring Doctor-Patient-Communication Experimental: primo control Participants get welcome at the entry point of the hospital, they will attend a general check-up with a GP or other services and they are not provided with by the study with VRI Participants get welcome at the entry point of the hospital, they are not provided with VRI. At the end of the hospital visit, they will complete a scale measuring Doctor-Patient-communication

Study Record Dates

• First Submitted: July 17, 2023
• First Posted: July 28, 2023
• Study Start: August 24, 2023
• Primary Completion: July 14, 2024
• Study Completion: July 14, 2024
• Last Updated: November 29, 2023

Record last verified: 2023-11

Data Sharing

• IPD Sharing: Will not share

Locations

CO (2)